Prostate Cancer
Colorectal cancer risk increases in prostate cancer patients on androgen deprivation therapy
Published in Obesity and Diabetes Week, November 22nd, 2010
Androgen deprivation therapy is a widely-prescribed treatment in men with prostate cancer, although its usage for low-risk disease remains controversial, given the adverse side effects, including osteoporosis, cardiovascular disease, diabetes and obesity; the last two are risk factors for colorectal cancer.
To determine whether prostate cancer patients taking androgen deprivation therapy are at an increased risk of colon cancer, Silke...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Bariatrics
Data on bariatrics discussed by researchers at University of California, Medical Department - Diabetes
CellerateRX(R) Effectively Manages Diabetic Ulcers ... New CDC Report Indicates Type 2 Diabetes on the Rise...Diabetes Projected to Affect Up to 1 in 3 Americans by 2050 - Diabetes
Data on diabetes published by researchers at Jewish General Hospital - Diabetes
Fat cells reach their limit and trigger changes linked to type 2 diabetes - Diabetes
Investigators at University of Regensburg, Department of Internal Medicine I target diabetes - Electronic Medical Records
New data from Cleveland Clinic illuminate research in electronic medical records - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
